Portfolio company
Alleviant
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alleviant Medical
This medical device company develops a minimally invasive interatrial shunt therapy without a permanent implant to treat patients suffering from heart failure.
INTERATRIAL SHUNT THERAPY
Alleviant Medical develops a minimally invasive, no-implant interatrial shunt system to treat heart failure by reducing left atrial pressure.
Corvia Medical
This company develops an atrial shunt to treat patients suffering from heart failure with preserved or mildly reduced ejection fraction.
V-Wave
This company develops implantable interatrial shunts to regulate heart pressure and reduce hospitalisations for patients suffering from chronic heart failure.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
Cardiac Dimensions
This company develops minimally invasive heart implants to treat functional mitral regurgitation in patients with heart failure.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
Levron
This company develops a cardio-respiratory physiological assist device that synchronises heart rhythm with respiratory dynamics for patients with chronic heart failure.